JosephJoe LukoseVadakaraMDFACP

Oncology • Danville, PA

Hematologic Oncology

Geisinger Hematology Oncology

Join to view full profile

Dr. Vadakara is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Vadakara's full profile

Already have an account?

Office
100 N Academy Avenue
Danville, PA 17822
Phone+1 570-271-6045

Fax+1 570-271-6542
Is this information wrong?

Education & Training

Temple University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
Drexel University College of Medicine/Hahnemann University HospitalChief Residency, Internal Medicine, 2009 - 2010
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2006 - 2009
University of Kerala Medical CollegeClass of 2004

Certifications & Licensure

PA State Medical License 2006 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma Start of enrollment: 2010 Sep 01
Completed
Phase 2
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
Active, not recruiting
Phase 3
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma Start of enrollment: 2012 Sep 01
Active, not recruiting
Phase 2
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Dec 06
Active, not recruiting
Phase 3
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2014 May 19
Active, not recruiting
Phase 3
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma Start of enrollment: 2015 Sep 08
Active, not recruiting
Phase 3
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Start of enrollment: 2015 Aug 27
Completed
Phase 2
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2016 Oct 12
Active, not recruiting
Phase 3
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Start of enrollment: 2015 Aug 17
Active, not recruiting
Phase 2
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery Start of enrollment: 2015 Aug 13
Completed
Phase 2
High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery Start of enrollment: 2015 Nov 10
Active, not recruiting
Phase 3
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Start of enrollment: 2015 Dec 01
Active, not recruiting
Phase 3
The National Myelodysplastic Syndromes (MDS) Study Start of enrollment: 2016 Jun 13
Recruiting
Join now to see all

Publications & Presentations

PubMed

Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs.
Vivek Narayan, Tao Liu, Yunjie Song, Joshua Mitchell, JoRean Sicks, Ilana Gareen, Lova Sun, Srinivas Denduluri, Ciaran Fisher, Jesse Manikowski, Mark Wojtowicz, Joseph...> ;Journal of the National Comprehensive Cancer Network. 2023 Oct 1
Rituximab in the Treatment of Acquired Angioedema Secondary to Marginal Zone Lymphoma of the Spleen.
Joseph Vadakara, Wu, K., Kathie Wu> ;Cureus. 2023 Mar 1
The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework Analysis.
Benjamin Andrick, Lorraine Tusing, Laney K Jones, Yirui Hu, Rachel Sneidman, Christina Gregor, Soumit Basu, Joseph P Lynch, Joseph Vadakara> ;Transplantation and Cellular Therapy. 2022 Jun 1
2 citations
Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapy.
Na Tosha Gatson, Mina Makary, Shane Bross, Joseph Vadakara, Tristan Maiers, Gino Mongelluzzo, Erika Leese, Cameron Brimley, Ekokobe Fonkem, Anand Mahadevan, Atom Sarka...> ;Neuro-Oncology Practice. 2021 May 26
288 citations
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon, Adam H. Buchanan, Isaac Kinde, Andrew Warren, Ashley Honushefsky, Ariella Cohain, David H. Ledbetter, Fred Sanfilippo, Kathleen Sheridan, Dillenia R...> ;Science. 2020 Jul 3
1 citations
Case Report of Immuno-Oncotherapy (IO) Provoked Encephalitis Mimicking Brain Metastasis in a Patient with History of Traumatic Brain Injury.
Shane P. Bross, Gino Mongelluzzo, Andrew Conger, Mayur A. Patel, Joseph Vadakara, Michelle Grant, Na Tosha Gatson> ;World Neurosurgery. 2020 Jul 1
3 citations
Early imaging marker of progressing glioblastoma: a window of opportunity
Na Tosha Gatson, Shane Bross, Yazmin Odia, Gino Mongelluzzo, Yirui Hu, Laura B. Lockard, Jesse J. Manikowski, Anand Mahadevan, Syed A. Jaffar Kazmi, Michel Lacroix, An...> ;Journal of Neuro-Oncology. 2020 Jun 29
112 citations
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Dmitriy Berenzon, Maria R. Baer, Ellen K. Ritchie, Richard T. Silver, Craig M. Kessler, Ellio...> ;Blood. 2019 Oct 31
18 citations
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.
John Mascarenhas, Heidi E. Kosiorek, J. T. Prchal, Abdulraheem Yacoub, Dmitriy Berenzon, Maria R. Baer, Ellen K. Ritchie, Richard T. Silver, Craig M. Kessler, Elliot F...> ;Leukemia. 2019 Jul 30
3 citations
Current advances in Hodgkin's lymphoma.
Joseph Vadakara, Benjamin Andrick> ;Chronic Diseases and Translational Medicine. 2019 Mar 1
3 citations
Thrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ER.
Kamia Thakur, Vaibhav Agrawal, Ashley Kass, Lauren M. DiMarino, R. Patrick Dorion, Joseph Vadakara> ;Case Reports in Hematology. 2017 May 18
13 citations
Etiologies and Short-Term Mortality in Patients with Ultraelevated Serum Ferritin.
Timothy Beer, Joseph Vadakara> ;Southern Medical Journal. 2015 Sep 1
27 citations
Gastrointestinal Stromal Tumors: Management of Metastatic Disease and Emerging Therapies
Joseph Vadakara, Margaret von Mehren> ;Hematology/oncology Clinics of North America. 2013 Oct 1
6 citations
Targeting CD30 in anaplastic large cell lymphoma.
Joseph Vadakara, Barbara Pro> ;Current Hematologic Malignancy Reports. 2012 Oct 14
19 citations
Personalized medicine and treatment approaches in non-small-cell lung carcinoma
Joseph Vadakara, Hossein Borghaei> ;Pharmacogenomics and Personalized Medicine. 2012 Sep 25
Join now to see all